Wealth Management Solutions’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$783K Buy
5,252
+10
+0.2% +$1.47K 0.54% 21
2023
Q2
$706K Buy
5,242
+20
+0.4% +$2.93K 0.46% 24
2023
Q1
$832K Sell
5,222
-204
-4% -$31.2K 0.48% 23
2022
Q4
$877K Sell
5,426
-388
-7% -$59.5K 0.46% 28
2022
Q3
$780K Sell
5,814
-220
-4% -$31.6K 0.45% 26
2022
Q2
$924K Sell
6,034
-1,391
-19% -$213K 0.52% 27
2022
Q1
$1.2M Sell
7,425
-802
-10% -$116K 0.63% 27
2021
Q4
$1.11M Buy
+8,227
New +$972K 0.57% 30

Other funds holding ABBV

Wealth Management Solutions's ABBV Position: Q3 2023 in Review

Wealth Management Solutions increased its AbbVie (ABBV) stake by 0.19% in Q3 2023, buying an estimated $1.47K and bringing the position to 5,252 shares worth $783K. The position accounts for 0.54% of the portfolio, ranked #21.

Wealth Management Solutions first reported a position in ABBV in Q4 2021 and has held it in 8 quarters since. The position peaked at $1.2M in Q1 2022. 3,109 funds tracked by Wall St. Rank hold ABBV as of Q3 2023.

  • Wealth Management Solutions held 5,252 shares of AbbVie worth $783K as of Q3 2023.
  • Wealth Management Solutions bought 10 AbbVie shares in Q3 2023, an estimated $1.47K.
  • AbbVie made up 0.54% of Wealth Management Solutions's portfolio in Q3 2023, its #21 holding.
  • Wealth Management Solutions first reported a position in AbbVie in Q4 2021 and has held it in 8 quarters since.
  • Wealth Management Solutions's AbbVie position peaked at $1.2M in Q1 2022.
  • 3,109 funds tracked by Wall St. Rank held AbbVie as of Q3 2023.

Based on Wealth Management Solutions's 13F filing for Q3 2023, filed 25 Oct 2023.